Chiasma Receives Orphan Drug Designation From The FDA For Octreolin™ For The Oral Treatment Of Acromegaly
Links shared publicly online about this topic.
- 1,059total visits
Chiasma Receives Orphan Drug Designation From The FDA For Octreolin™ For The Oral Treatment Of Acromegaly
View full resource at medicalnewstoday.com
Tags: Acromegaly, Drug, FDA
Most Recently Shared on June 30, 2010 at 1:05 am By:
Chiasma Receives Orphan Drug Designation From The FDA For Octreolin™ For The Oral Treatment Of Acromegaly http://mnt.to/3FtJ
Also Shared By:
Orphan drug designation granted to Octreolin for oral treatment of acromegaly - MPR
empr.com — “Chiasma, Inc. was granted orphan drug designation by the FDA for Octreolin, for the oral treatment of acromegaly, a hormonal disorder that results from an excess of growth hormone.” View full resource at empr.com
Most Recently Shared on June 28, 2010 at 9:23 pm By:
MPR News: Orphan drug designation granted to Octreolin for oral treatment of acromegaly: Chiasma, Inc. was granted... http://bit.ly/96Qd2i
Chiasma Receives Orphan Drug Designation From the FDA for Octreolin" for... -- NEW YORK and JERUSALEM, June 28 /PRNewswire/ --
prnewswire.com — “Chiasma Receives Orphan Drug Designation From the FDA for Octreolin" for the Oral Treatment of Acromegaly.” View full resource at prnewswire.com
Most Recently Shared on June 28, 2010 at 1:18 pm By:
eyeonfda Pharma and Health Lawyer
Chiasma Receives Orphan Drug Designation From the FDA for Octreolinâ„¢ for the Oral Treatment of Acromegaly - http://ow.ly/247Nu
Advertisement
MNT Endocrinology
@mnt_endocrine
Chiasma Receives Orphan Drug Designation From The FDA For Octreolin™ For The Oral Treatment Of Acromegaly http://mnt.to/3FtJ
1 year ago...